NAMPT and polycystic ovary syndrome: We further confirmed the protective role of NAD+ production in PCOS by treating mice with FK866, an inhibitor of nicotinamide phosphoribosyltransferase (NAMPT), which is the rate‐limiting enzyme in the NAD+ salvage pathway[12] (Figure 5A).